As of January 23, 2025, Relmada Therapeutics (RLMD) has a market cap of $11.765 million USD. According to our data, Relmada Therapeutics is ranked No.8809 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 23, 2025 | $11.76 M |
-25.02%
|
Dec 31, 2024 | $15.69 M |
-87.44%
|
Dec 29, 2023 | $0.12 B |
18.62%
|
Dec 30, 2022 | $0.11 B |
-84.51%
|
Dec 31, 2021 | $0.68 B |
-29.75%
|
Dec 31, 2020 | $0.97 B |
-17.77%
|
Dec 31, 2019 | $1.18 B |
747.83%
|
Dec 31, 2018 | $0.14 B |
53.33%
|
Dec 29, 2017 | $90.52 M |
-31.19%
|
Dec 30, 2016 | $0.13 B |
-56.40%
|
Dec 31, 2015 | $0.30 B |
-83.87%
|
Dec 31, 2014 | $1.87 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Johnson & Johnson
JNJ
|
$349.75 B |
0.001 M
|
USA
|
Pfizer
PFE
|
$147.40 B |
-0.003 M
|
USA
|
Eli Lilly
LLY
|
$678.07 B |
0.022 M
|
USA
|
AbbVie
ABBV
|
$299.00 B |
-0.007 M
|
USA
|
Bristol-Myers Squibb
BMY
|
$115.79 B |
-0.003 M
|
USA
|
Merck
MRK
|
$242.04 B |
-0.000 M
|
USA
|
Amgen
AMGN
|
$146.98 B |
0.004 M
|
USA
|
Gilead Sciences
GILD
|
$115.95 B |
0.002 M
|
USA
|
Biogen
BIIB
|
$20.80 B |
0.000 M
|
USA
|
Regeneron Pharmaceuticals
REGN
|
$74.73 B |
1.236 B
|
USA
|
Alkermes
ALKS
|
$4.89 B |
-0.000 M
|
Ireland
|
Jazz Pharmaceuticals
JAZZ
|
$7.31 B |
0.000 M
|
Ireland
|
Sage Therapeutics
SAGE
|
$0.43 B |
-0.000 M
|
USA
|
Axsome Therapeutics
AXSM
|
$4.96 B |
0.000 M
|
USA
|
Market Cap | = | RLMD Stock Price | * | RLMD Shares Outstanding |
= | $0.39 | * | 30.17 M | |
= | $11.76 M |